Insulin-like Growth Factor-1 IGFBP-3 rDNA

Insulin-like Growth Factor-1 rDNA Chiron

Insulin-like Growth Factor-1 rDNA Tercica

Insulin like Growth Factor 1 Receptor IGF 1R

Although the insulin-like growth factor-1 receptor (IGF-1R) was first cloned in 1986, it was the success of targeted drugs such as trastuzumab and imatinib that tyrosine kinase inhibitors and growth...

Insulin

Insulin: Charting the SH2 pool

New research describes a large set of interactions (interactome) which maps the range of phosphotyrosine (pTyr)-dependent interactions with SH2 domains underlying insulin (Ins), insulin-like growth fa...

Can Serum Insulin-like Growth Factor 1 Delay Facial Ageing?

Does insulin-like growth factor 1 play a role in skin wrinkling? The British Journal of Dermatology

FDA delays decision on Novo's insulin products

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) said FDA extended the PDUFA date by three months for NDAs for insulin Degludec and insulin Degludec/insulin aspart to treat Type I and II diabetes. The new date is...

FDA to discuss Novo's insulin products

FDA confirmed the Nov. 8 meeting date for the Endocrinologic and Metabolic Drugs Advisory Committee to discuss NDAs from Novo Nordisk A/S (CSE:NVO; NYSE:NVO) for insulin Degludec and insulin Degludec/...

Novo cautious on 2013 as it awaits new insulin approval

COPENHAGEN (Reuters) - Denmark's Novo Nordisk on Wednesday gave a cautious outlook for 2013, reflecting uncertainty over approval for its new long-acting insulin in the United States and slowing globa...

How insulin engages its primary binding site on the insulin receptor

Insulin receptor signalling has a central role in mammalian biology, regulating cellular metabolism, growth, division, differentiation and survival. Insulin resistance contributes to the pathogenesis...

CORRECTED-UPDATE 2-Novo cautious on 2013 as it awaits new insulin approval

COPENHAGEN, Oct 31 (Reuters) - Denmark's Novo Nordisk on Wednesday gave a cautious outlook for 2013, reflecting uncertainty over approval for its new long-acting insulin in the United States and slow...

Meeting scheduled for insulin degludec and insulin degludec/insulin aspart

Meeting scheduled to discuss the NDA for the ultra-long-acting insulin degludec & insulin degludec/insulin aspart....

Insulin-like growth factor1 (IGF-I) improves hepatic differentiation of human bone marrow-derived mesenchymal stem cells.

Abstract The ability of mesenchymal stem cells (MSCs) to differentiate into other cell types makes these cells an attractive therapeutic tool for cell transplantation. This project was designed to imp...

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report.

ABSTRACT: INTRODUCTION: Adult Growth hormone Deficiency is a well known phenomenon effecting both males and females. Adult Growth Hormone Deficiency is marked by a number of neuropsychiatric, cognitiv...

Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis.

Obesity-associated carcinogenesis is postulated to be mediated through the proliferative actions of insulin and the insulin-like growth factor (IGF) family. The aim of this study was to determine whet...

The role of insulin growth factor on atherosclerosis and endothelial function: The effect on hyperlipidemia and aging.

Insulin/insulin-like growth factor (IGF-1) signaling is important for a variety of age-related processes. However, whether or not it affects atherosclerosis is unknown.

Insulin-like growth factor and insulin-like growth factor-binding proteins in the bovine uterus throughout the oestrous cycle.